|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saraf AJ, Fenger JM and Roberts RD:
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future.
Front Oncol. 8:42018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaughnessy R and Echard A: Rab35 GTPase
and cancer: Linking membrane trafficking to tumorigenesis. Traffic.
19:247–252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang S, Hu C, Wu F and He S: Rab25 GTPase:
Functional roles in cancer. Oncotarget. 8:64591–64599. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bao X, Faris AE, Jang EK and Haslam RJ:
Molecular cloning, bacterial expression and properties of Rab31 and
Rab32. Eur J Biochem. 269:259–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan Y, Zhang Y, Chen L, Liu Y, Feng Y and
Yan J: The Critical role of Rab31 in cell proliferation and
apoptosis in cancer progression. Mol Neurobiol. 53:4431–4437. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sui Y, Zheng X and Zhao D: Rab31 promoted
hepatocellular carcinoma (HCC) progression via inhibition of cell
apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol.
36:8661–8670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grismayer B, Sölch S, Seubert B, Kirchner
T, Schäfer S, Baretton G, Schmitt M, Luther T, Krüger A, Kotzsch M,
et al: Rab31 expression levels modulate tumor-relevant
characteristics of breast cancer cells. Mol Cancer. 11:622012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Xu J, Yang G, Li H and Guo X:
miR-202 inhibits cell proliferation, migration, and invasion by
targeting EGFR in human bladder cancer. Oncol Res. 26:949–957.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang R and Xia T: Long non-coding RNA
XIST regulates PDCD4 expression by interacting with miR-21-5p and
inhibits osteosarcoma cell growth and metastasis. Int J Oncol.
51:1460–1470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qu Q, Chu X and Wang P: MicroRNA-195-5p
suppresses osteosarcoma cell proliferation and invasion by
suppressing naked cuticle homolog 1. Cell Biol Int. 41:287–295.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du JY, Wang LF, Wang Q and Yu LD: miR-26b
inhibits proliferation, migration, invasion and apoptosis induction
via the downregulation of
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven
glycolysis in osteosarcoma cells. Oncol Rep. 33:1890–1898. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng WD, Zhou FL and Lin N: MicroRNA-26b
inhibits osteosarcoma cell migration and invasion by
down-regulating PFKFB3 expression. Genet Mol Res. 14:16872–16879.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Sun Z, Liu B, Shan Y, Zhao L and Jia
L: Tumor-suppressive miR-26a and miR-26b inhibit cell
aggressiveness by regulating FUT4 in colorectal cancer. Cell Death
Dis. 8:e28922017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li YP, Dai WM, Huang Q, Jie YQ, Yu GF, Fan
XF, Wu A and Mao DD: Effects of microRNA-26b on proliferation and
invasion of glioma cells and related mechanisms. Mol Med Rep.
16:4165–4170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan G, Ren C, Zhang Y and Feng S:
MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF
and Smad1. Tumour Biol. 36:6201–6209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
eLife. 4:42015. View Article : Google Scholar
|
|
27
|
Kotzsch M, Sieuwerts AM, Grosser M, Meye
A, Fuessel S, Meijer-van Gelder ME, Smid M, Schmitt M, Baretton G,
Luther T, et al: Urokinase receptor splice variant
uPAR-del4/5-associated gene expression in breast cancer:
Identification of rab31 as an independent prognostic factor. Breast
Cancer Res Treat. 111:229–240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin C, Rajabi H, Pitroda S, Li A,
Kharbanda A, Weichselbaum R and Kufe D: Cooperative interaction
between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen
receptor-positive breast cancer cells. PLoS One. 7:e394322012.
View Article : Google Scholar : PubMed/NCBI
|
